首頁 > 美迪醫訊 > Antiallergic drugs market report |
Antiallergic drugs market report 【?2008-07-17 發布?】 美迪醫訊
Antiallergic drugs market reportResearch report of Chinese antiallergic drugs market
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:
Format: Hardcopy and Adobe PDF
Price: US$3,800
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Brief introduction
The report presents a detail analysis on Chinese hospital and retail market of antiallergic drugs, based on the impersonal data。With the report you can know Chinese status of antiallergic drugs market and development opportunities。The report discloses the market scale, sales trend, and sales status of key brands(enterprises)。In the report the key breeds contains Loratadine, Cetirizine, Mizolastine, Ebastine, Desloratadine etc.
The report consist of 181 tables and figures, 103 pages, 28 thousand words.
The table of contents
Summary
Chapter 1 Sales analysis of hospital market
1 Overview of Sales status
1.1 Market scales and sales trend from 2002 to 2005
1.2 Market shares of differetn breeds from 2002 to 2005
1.3 Market shares of antiallergic drugs with different administration routes
2 Sales analysis of key breeds
2.1 Loratadine
2.1.1 Market share of Loratadine in antiallergic drugs market form 2002 to 2005
2.1.2 Market share of different enterprises form 2002 to 2005
2.1.3 Sales statistic of Schering-Plough Pharmaceuticals Co., Ltd
2.1.4 Sales statistic of Sanmenxia Sinoway pharmaceutical Co., Ltd
2.1.5 Sales statistic of Beijing SL Pharmaceutical Co.,Ltd.
2.1.6 Sales statistic of Changzhou Siyao pharmaceutical Co.,LTD
2.1.7 Sales statistic of Shenzhen neptunus Pharmaceutical Co.,Ltd
2.1.8 Sales statistic of Zhejiang Jingxin Pharmaceutical Co., Ltd
2.2 Cetirizine
2.2.1 Market share of Cetirizine in antiallergic drugs market form 2002 to 2005
2.2.2 Market share of different enterprises form 2002 to 2005
2.2.3 Sales statistic of Belgium UCB Pharma S.p.A
2.2.4 Sales statistic of Shandong Lunan Pharmaceutical Group Corporation
2.2.5 Sales statistic of Suzhou Dawnrays Pharmaceutial (Holdings) Limited
2.2.6 Sales statistic of India Sun Pharmaceutial Industries Ltd.
2.2.7 Sales statistic of Chongqing Huapont Pharmaceutical Co., Ltd
2.2.8 Sales statistic of Chengdu MinYi Pharmaceutical Co., Ltd
2.3 Mizolastine
2.3.1 Market share of Mizolastine in antiallergic drugs market form 2002 to 2005
2.3.2 Market share of different enterprises form 2002 to 2005
2.3.3 Sales statistic of Xian Janssen Pharmaceutical Co.,Ltd
2.4 Desloratadine
2.4.1 Market share of Desloratadine in antiallergic drugs market form 2002 to 2005
2.4.2 Market share of different enterprises form 2002 to 2005
2.4.3 Sales statistic of Shenzhen Salubris Pharmaceutical Co.,Ltd
2.4.4 Sales statistic of Hainan Poly Pharmaceutical Co., Ltd
2.4.5 Sales statistic of Shenzhen Haibin Pharmaceutical Co., Ltd
2.4.6 Sales statistic of Schering-Plough Pharmaceuticals Co., Ltd
2.5 Ebastine
2.5.1 Market share of Ebastine in antiallergic drugs market form 2002 to 2005
2.5.2 Market share of different enterprises form 2002 to 2005
2.5.3 Sales statistic of Eisai (Suzhou) Co., Ltd
2.5.4 Sales statistic of Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co.Ltd
2.5.5 Sales statistic of Hangzhou Aoyipollen Pharmaceutical Co. Ltd
2.6 Chlorcylizine
2.6.1 Market share of Chlorcylizine in antiallergic drugs market form 2002 to 2005
2.6.2 Market share of different enterprises form 2002 to 2005
2.6.3 Sales statistic of Jiaozuo Kangli Pharmaceutical Co., Ltd
2.7 Mequitazine
2.7.1 Market share of Mequitazine in antiallergic drugs market form 2002 to 2005
2.7.2 Market share of different enterprises form 2002 to 2005
2.7.3 Sales statistic of Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co.Ltd
2.8 Astemizole
2.8.1 Market share of Astemizole in antiallergic drugs market form 2002 to 2005
2.8.2 Market share of different enterprises form 2002 to 2005
2.8.3 Sales statistic of Xian Janssen Pharmaceutical Co.,Ltd
2.9 Triprolidine
2.9.1 Market share of Triprolidine in antiallergic drugs market form 2002 to 2005
2.9.2 Market share of different enterprises form 2002 to 2005
2.9.3 Sales statistic of Xianggan Federal Pharmaceutical Company, Ltd
2.10 Levocetirizine
2.10.1 Sales statistic of Chongqing Huapont Pharmaceutical Co., Ltd
2.11 Others(Fexofenadine 、Setastine etc.)
3 Sales analysis of antiallergic drugs of hormone class
3.1 Budesonide
3.1.1 Market share of Budesonide in antiallergic drugs market form 2002 to 2005
3.1.2 Market share of different enterprises form 2002 to 2005
3.1.3 Sales statistic of AstraZeneca Pharmaceutical Co Ltd
3.1.4 Sales statistic of Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd
3.1.5 Shandong Lunan Pharmaceutical Group Corporation
3.2 Beclometasone
3.2.1 Market share of Beclometasone in antiallergic drugs market form 2002 to 2005
3.2.2 Market share of different enterprises form 2002 to 2005
3.2.3Sales statistic of GlaxoSmithKline Plc
3.3 Fluticasone
3.3.1 Market share of Fluticasone in antiallergic drugs market form 2002 to 2005
3.3.2 Market share of different enterprises form 2002 to 2005
3.3.3 Sales statistic of GlaxoSmithKline Plc
4、Sales analysis of antiallergic drugs of allergic mediator release inhibitors
4.1 Ketotifen
&nb
本文關鍵字:
《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢《上海醫療器械批發》產品推薦
|
合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
把美迪網放進收藏夾 把美迪醫療網介紹給我的朋友 給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303 美迪醫療網業務咨詢 互聯網藥品信息服務許可證:(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8 公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號 營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |